Presidio’s Insider Buy of CARLSMED Shares Signals Strong Future Growth
Insiders at Presidio Management Group buy 200k CARLSMED shares at $15, below market, signaling confidence in the company’s growth and clinical pipeline.
3 minutes to read
CARLSMED INC
CARLSMED COO Exercises 50,000 Stock Options, Boosting Investor Confidence in AI Spine Tech
CARLSMED COO Jeff Bertolini’s 50k option exercise signals strong insider confidence, hinting at a rebound for the AI‑driven spine platform.
3 minutes to read